XML 85 R61.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders’ Equity and Stock-Based Compensation (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 23, 2024
Jan. 27, 2023
Mar. 30, 2024
Sep. 24, 2022
Jun. 25, 2022
Dec. 28, 2024
Dec. 31, 2022
Jun. 06, 2024
Dec. 30, 2023
Dec. 26, 2020
Subsidiary, Sale of Stock [Line Items]                      
Number of common stock sold, shares 2,405,000 37,550,000 17,000,000                
Proceeds from issuance of common stock             $ 33,900,000        
Proceeds from issuance of warrants $ 1,600,000                    
Common stock, par value             $ 0.01   $ 0.01 $ 0.01  
Common stock shares authorized             200,000,000     150,000,000  
Unrecognized compensation expense             $ 5,700,000        
Weighted average period             2 years        
2020 Equity Incentive Plan [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Common stock shares authorized                     11,000,000
Number of shares authorized to issue                     4,000,000
Number of shares available for grant             4,900,000        
Vesting period description             the Company for periods ranging from one to five years (the vesting period)        
Minimum [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Common stock shares authorized                 150,000,000    
Vesting period description             the Company for periods ranging from one to five years (the vesting period)        
Maximum [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Common stock shares authorized                 200,000,000    
Prefunded Warrants [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Underwriting discounts and offering expenses   $ 1,800,000 $ 1,500,000                
Pre-funded warrants issued to purchase common stock   4,000,000 6,000,000                
Offering price per share   $ 0.64 $ 0.99                
Proceeds from issuance of warrants   $ 27,000,000.0 $ 22,900,000                
Exercise price of warrants   $ 0.01 $ 0.01                
Common Stock [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Number of common stock sold, shares             43,000,000.0        
At The Market Offering [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Number of common stock sold, shares               126,389      
Payment of expenses           $ 100,000          
Underwriting discounts and offering expenses         $ 100,000            
Proceeds from sale of common stock               $ 200,000      
Commissions paid               $ 10,000      
At The Market Offering [Member] | Common Stock [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Number of common stock sold, shares       3,080,000 675,000 1,500,000          
Gross proceeds from registered sale equity securities       $ 7,466,755   $ 2,100,000          
Share price       $ 2.42 $ 1.27 $ 1.26          
Proceeds from issuance of common stock         $ 900,000            
Proceeds from issuance of common stock       $ 200,000              
At The Market Offering [Member] | Treasury Stock, Common [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Number of common stock sold, shares           200,000